HIGHLIGHTS
- who: Yuchen Guo and colleagues from the Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China have published the article: TERT Promoter Mutations and Telomerase in Melanoma, in the Journal: Journal of Oncology of 19/07/2022
- how: The results showed that the presence of TERT promoter mutations was significantly related to the risk of extra lymph node metastasis or death from Spitzoid melanoma.
- future: Independent prospective studies are needed to assess the reliability of TERT promoter mutations as an independent prognostic factor for melanoma . Telomerase inhibition may be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.